|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-3-20
|
|
pubmed:abstractText |
Whereas there seems to be little, if any, circadian variation in circulating concentrations of IGF-I and IGFBP-3 in healthy subjects, there are conflicting reports on this issue in GH-deficient patients treated with GH as a daily subcutaneous injection. We have therefore investigated the 24-hour serum profiles of IGF-I and IGFBP-3 concentrations after one week and more than one year of GH treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
63-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9059559-Adult,
pubmed-meshheading:9059559-Circadian Rhythm,
pubmed-meshheading:9059559-Female,
pubmed-meshheading:9059559-Growth Disorders,
pubmed-meshheading:9059559-Growth Hormone,
pubmed-meshheading:9059559-Human Growth Hormone,
pubmed-meshheading:9059559-Humans,
pubmed-meshheading:9059559-Injections, Subcutaneous,
pubmed-meshheading:9059559-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:9059559-Insulin-Like Growth Factor I,
pubmed-meshheading:9059559-Male,
pubmed-meshheading:9059559-Time Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults.
|
|
pubmed:affiliation |
Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
